MVP RCT: Mind and Voice Project Randomized Control Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04018807|
Recruitment Status : Completed
First Posted : July 15, 2019
Last Update Posted : August 7, 2020
|Condition or disease||Intervention/treatment||Phase|
|Physical Health Mental Health Alcohol; Use, Problem Interpersonal Violence||Other: Resource pamphlet Behavioral: Remote Therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||26 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||MVP RCT: Mind and Voice Project Randomized Control Trial|
|Actual Study Start Date :||July 22, 2019|
|Actual Primary Completion Date :||July 31, 2020|
|Actual Study Completion Date :||July 31, 2020|
Participants will receive a pamphlet detailing mental health and social service providers at the local, state, and national level.
Other: Resource pamphlet
The pamphlet will list violence prevention, mental health, and substance abuse services.
Experimental: Remote Therapy
Participants will receive eight 30-minute remote therapy sessions over the course of twelve weeks.
Behavioral: Remote Therapy
Remote therapy sessions will include mindfulness exercises and motivational interviewing techniques.
- Feasibility, as Measured by Number of Sessions Completed [ Time Frame: 12 weeks ]At least 80% of session content completed.
- Acceptability, as Measured by Client Satisfaction [ Time Frame: 12 weeks ]Client satisfaction is measured by the Client Satisfaction Questionnaire Exit-8, an 8 question survey where a high score indicates client satisfaction.
- Usability, as Measured by a Modified Systems Usability Scale [ Time Frame: 12 weeks ]System usability is measured by an adapted version of the Systems Usability Scale for the platform used.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04018807
|United States, Michigan|
|Hurley Medical Center|
|Flint, Michigan, United States, 48503|
|Principal Investigator:||Quyen Ngo, PhD||University of Michigan|